These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24423248)

  • 1. Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome.
    Tsai NW; Lee LH; Huang CR; Chang WN; Chang YT; Su YJ; Chiang YF; Wang HC; Cheng BC; Lin WC; Kung CT; Su CM; Lin YJ; Lu CH
    Crit Care; 2014 Jan; 18(1):R16. PubMed ID: 24423248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prestroke statins use reduces oxidized low density lipoprotein levels and improves clinical outcomes in patients with atrial fibrillation related acute ischemic stroke.
    He L; Xu R; Wang J; Zhang L; Zhang L; Zhao W; Dong W
    BMC Neurol; 2019 Oct; 19(1):240. PubMed ID: 31627722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A
    Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
    Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
    J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative Exposure to Oxidized Low-density Lipoprotein is a Potential Predictor for Prognosis in Acute Ischemic Stroke: A Cohort Study.
    Cheng K; Chen X; Luo Y; Sun W; Yang X; Huang S; Wang Y; Wu D
    Curr Pharm Des; 2024; 30(10):778-785. PubMed ID: 38424424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of statin therapy and high-sensitivity C-reactive protein level for predicting clinical outcome in acute non-cardioembolic ischemic stroke.
    Tsai NW; Lee LH; Huang CR; Chang WN; Chen SD; Wang HC; Lin YJ; Lin WC; Chiang YF; Lin TK; Cheng BC; Su YJ; Kung CT; Hung SH; Chang HW; Lu CH
    Clin Chim Acta; 2012 Nov; 413(23-24):1861-5. PubMed ID: 22892175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rise in Low-Density Lipoprotein Cholesterol during Hospitalization is Related with Poor Outcome at Discharge in Patients with Acute Ischemic Stroke.
    Yuan HW; Yang YN; Chen HF; Ji RJ; Lin YJ; Guo RY; Peng GP; Liang H; Luo B
    Cerebrovasc Dis; 2020; 49(1):88-96. PubMed ID: 31995799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; Luijckx GJ; De Keyser J
    J Neurol; 2008 Jun; 255(6):875-80. PubMed ID: 18338194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein cholesterol and the ratio in the diagnosis and evaluation of therapeutic effect in patients with coronary artery disease.
    Huang H; Ma R; Liu D; Liu C; Ma Y; Mai W; Dong Y
    Dis Markers; 2012; 33(6):295-302. PubMed ID: 23089925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in the prognostic value of the lipid profile after the first ischemic stroke.
    Cuadrado-Godia E; Jiménez-Conde J; Ois A; Rodríguez-Campello A; García-Ramallo E; Roquer J
    J Neurol; 2009 Jun; 256(6):989-95. PubMed ID: 19252778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission LDL-cholesterol, statin pretreatment and early outcomes in acute ischemic stroke.
    Kim JT; Lee JS; Kim BJ; Kang J; Lee KJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Lee K; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Yum KS; Sohn SI; Hong JH; Lee SH; Park MS; Choi KH; Lee J; Park KY; Bae HJ
    J Clin Lipidol; 2023; 17(5):612-621. PubMed ID: 37574400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
    Nishiyama Y; Ueda M; Otsuka T; Katsura K; Abe A; Nagayama H; Katayama Y
    J Atheroscler Thromb; 2011; 18(2):131-7. PubMed ID: 21081834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions.
    Homma K; Homma Y; Ozawa H; Shiina Y; Shibata T; Yoshida T; Hasegawa K; Kanda T; Tokuyama H; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(6):751-757. PubMed ID: 26687695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia.
    Tavridou A; Efthimiadis A; Efthimiadis I; Manolopoulos VG
    Heart Vessels; 2010 Jul; 25(4):288-93. PubMed ID: 20676836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpatient Statin Use Is Associated with Decreased Mortality of Acute Stroke Patients with Very Low Low-Density Lipoprotein Cholesterol.
    Song B; Wang Y; Zhao X; Liu L; Wang C; Wang A; Du W; Wang Y; Xu Y
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2369-74. PubMed ID: 26303789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.
    Paniagua JA; López-Miranda J; Pérez-Martínez P; Marín C; Vida JM; Fuentes F; Fernández de la Puebla RA; Pérez-Jiménez F
    Diabet Med; 2005 Dec; 22(12):1647-56. PubMed ID: 16401307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke.
    Tsai NW; Lin TK; Chang WN; Jan CR; Huang CR; Chen SD; Cheng KY; Chiang YF; Wang HC; Yang TM; Lin YJ; Lin WC; Chang HW; Lee LH; Lu CH
    Crit Care; 2011 Jul; 15(4):R163. PubMed ID: 21740551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The Standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trial.
    Nishikido T; Oyama J; Keida T; Ohira H; Node K
    J Cardiol; 2016 Apr; 67(4):340-6. PubMed ID: 26162946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.